Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Abundant Intravenous Normal Saline Infusion for Stroke After Intravenous Thrombolysis
NCT07497542Phase 3Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Apr 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 3 trial of Normal Saline-Benha University in ischemic stroke, sponsored by Tianjin Medical University General Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
Normal Saline-Benha University
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07497542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497542.